1. |
Xiang L, Zhou TJ, Zhou LL, et al. Influenza a virus and streptococcus pneumonia coinfection potentially promotes bacterial colonization and enhances B lymphocyte depression and reduction. J Biol Regul Homeost Agents, 2019, 33(5): 1437-1449.
|
2. |
Zhang J, Deng R, Jia H, et al. Risk factors and peripheral blood lymphocyte subset analysis of patients with ventilator-associated pneumonia: a Chinese population-based study. Int J Clin Exp Pathol, 2019, 12(10): 3830-3838.
|
3. |
李娜, 穆亚平, 陈静, 等. 淋巴细胞亚群绝对计数对儿童难治性肺炎支原体肺炎的早期预测作用. 中国当代儿科杂志, 2019, 21(6): 511-516.
|
4. |
Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol, 2013, 11(12): 836-848.
|
5. |
Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol, 2020, 92(4): 424-432.
|
6. |
Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus-a perspective. Expert Rev Clin Immunol, 2020, 6(4): 1-6.
|
7. |
国家卫生健康委办公厅. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知. 中华人民共和国国家卫生健康委员会, 2020-03-03.
|
8. |
中央赴湖北等疫情严重地区指导组. 关于进一步完善新型冠状病毒肺炎重型、危重型病例诊疗方案的通知. 中央指导组, 2020-03-03.
|
9. |
Ali SB, Jeelall Y, Pennell CE, et al. The role of immunological testing and intervention in reproductive medicine: A fertile collaboration? Am J Repro Immunol, 2018, 79(3): 10.1111/aji.12784.
|
10. |
李婕, 李怡, 冯瑞琳, 等. 昆明HIV感染吸毒者 CD4+ T淋巴细胞水平与CD4/CD8 比值调查分析. 国际病毒学杂志, 2019, 26(3): 157-160.
|
11. |
李建国, 陈瑞, 魏菁. SARS患者急性期外周血CD3+、CD4+及CD8+细胞数量的变化. 免疫学杂志, 2004, 20(5): 382-384.
|
12. |
张益明, 高世定, 王占科, 等. 3例新型冠状病毒肺炎患者外周血CD4+T淋巴细胞和CD4+/CD8+比值变化. 国际检验医学杂志, 2020. [Epub ahead of print].
|
13. |
Zheng HY, Zhang M, Yang CX, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol, 2020, 17(5): 541-543.
|
14. |
卢子龙, 何如愿, 江文洋, 等. COVID-19患者临床特征及免疫功能分析. 武汉大学学报(医学版), 2020. [Epub ahead of print].
|
15. |
Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest, 2020, 130(5): 2620-2629.
|
16. |
Xiong Y, Liu Y, Cao L, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect, 2020, 9(1): 761-770.
|
17. |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020, 8(4): 420-422.
|
18. |
Shi SB, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol, 2020, e200950.
|
19. |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
|
20. |
Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol, 2002, 2(9): 706-713.
|